Back to Search Start Over

Quantitative preoperative patient assessments are related to survival and procedure outcome for osseous metastases.

Authors :
Bartelstein, Meredith K.
Forsberg, Jonathan A.
Lavery, Jessica A.
Yakoub, Mohamed A.
Akhnoukh, Samuel
Boland, Patrick J.
Fabbri, Nicola
Healey, John H.
Source :
Journal of Bone Oncology; Jun2022, Vol. 34, pN.PAG-N.PAG, 1p
Publication Year :
2022

Abstract

• Presurgical assessments are associated with survival of patients with bone metastases. • SF-36 vitality and general and mental health are strongly associated with survival. • Patient-reported assessments may help with surgical planning. Our objective was to determine if preoperative patient-reported assessments are associated with survival after surgery for stabilization of skeletal metastases. All patients with metastatic cancer to bone and indications for skeletal stabilization surgery were approached to participate in a prospective cohort study at a tertiary care center from 2012 to 2017. Of the 208 patients who were eligible, 195 (94%) completed the 36-item Short Form Health Survey (SF-36) preoperatively and underwent surgical treatment of skeletal metastases with complete or impending fractures; the sample encompassed a range of cancer diagnoses and included cases of both internal fixation and endoprosthetic replacement. Cox proportional hazards models were used to identify associations between SF-36 scores and survival. In a model adjusted for clinical factors, patients' mental and physical SF-36 component summary scores were significantly associated with survival, as was their SF-36 composite score (P = 0.004, P = 0.015, and P < 0.001, respectively). Scores in the general health, vitality, and mental health domains were each strongly associated with survival (P < 0.001). Patients' preoperative assessments of their health status are associated with their survival after surgery for skeletal metastases. Patient-reported assessments have the potential to contribute unique information to models that estimate patient survival, as part of efforts to provide optimal, individualized care and make informed decisions about the type and magnitude of surgery for metastatic bone disease that will last the patient's lifetime. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22121366
Volume :
34
Database :
Supplemental Index
Journal :
Journal of Bone Oncology
Publication Type :
Academic Journal
Accession number :
157388177
Full Text :
https://doi.org/10.1016/j.jbo.2022.100433